Elite Pharma Inc
(ELTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 616 | 20,109 | 16,783 | 16,076 | 1,142 |
| Depreciation Amortization | 562 | 1,518 | 1,017 | 667 | 334 |
| Income taxes - deferred | 18 | -19,989 | -18,062 | -17,261 | N/A |
| Accounts receivable | -1,043 | -16,595 | -13,110 | -7,431 | -3,207 |
| Other Working Capital | -943 | -11,894 | -14,173 | -7,241 | -4,490 |
| Other Operating Activity | 3,934 | 23,616 | 22,210 | 12,245 | 3,512 |
| Operating Cash Flow | $3,145 | $-3,235 | $-5,335 | $-2,946 | $-2,710 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -763 | -810 | -406 | N/A | N/A |
| Purchase Sale Intangibles | -900 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -900 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,663 | $-810 | $-406 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 4,000 | 4,000 |
| Debt Repayment | -71 | 3,650 | 4,000 | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | -97 | N/A |
| Other Financing Activity | -104 | -311 | -260 | -125 | -43 |
| Financing Cash Flow | $-175 | $3,339 | $3,740 | $3,778 | $3,957 |
| Beginning Cash Position | 7,539 | 8,245 | 8,245 | 8,245 | 8,245 |
| End Cash Position | 8,845 | 7,539 | 6,244 | 9,077 | 9,492 |
| Net Cash Flow | $1,306 | $-706 | $-2,001 | $832 | $1,247 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,145 | -3,235 | -5,335 | -2,946 | -2,710 |
| Capital Expenditure | -779 | -810 | -406 | N/A | N/A |
| Free Cash Flow | 2,366 | -4,045 | -5,741 | -2,946 | -2,710 |